FZ-AD005

고객리뷰

Based on 1 Customer Validation

FZ-AD005 is an antibody-drug conjugate (ADC) that selectively targets DLL3, generated by conjugating the anti-DLL3 antibody FZ-A038 (HY-P990896) with a dipeptide linker (Val-Ala) and DXd (HY-13631D). FZ-AD005 binds human DLL3 with a Kd of 58.3 pM. FZ-AD005 binds cell-surface DLL3 and mediates internalization, followed by lysosomal cathepsin cleavage to release the payload DXd, which induces DNA double-strand breaks, cell cycle arrest, and apoptosis through inhibition of topoisomerase TopI, and exhibits a bystander killing effect on adjacent DLL3-negative cells. FZ-AD005 can be used for research on small cell lung cancer and human neuroendocrine prostate cancer.

연구목적의 판매만을 진행합니다. 환자를 대상으로 한 판매는 하지 않습니다.

  • Purity : 97.54%
  • 분자량:154128 (average)
  • 보관:
    Shipping with dry ice

    -80°C, protect from light

  • Biological Activity
  • Chemical Information
  • Protocol
  • 순도&문서
  • References
  • Help & FAQs

All Topoisomerase Isoforms

More
MOQ
Minimum order quantity
100 mg

견적 받기 해외재고보유

Other size
견적 받기
Please select quantity
Amount: USD 0.00